Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

676 recalls · Class II, newest first

Class II · Moderate risk

Acetaminophen Tablets

cGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets).

Ongoing Failed specification Aurobindo Pharma USA Inc NDC 72288-405-10 D-0471-2025
Class II · Moderate risk

Semaglutide

Lack of Assurance of Sterility

Ongoing Sterility / contamination Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) D-0480-2025
Class II · Moderate risk

Semaglutide

Lack of Assurance of Sterility

Ongoing Sterility / contamination Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) D-0479-2025
Class II · Moderate risk

LX Bioboost Plus

Lack of Assurance of Sterility

Ongoing Sterility / contamination Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) D-0477-2025
Class II · Moderate risk

Theophylline

OOS results reported for the Dissolution (by UV) test.

Ongoing Dissolution failure Glenmark Pharmaceuticals Inc., USA D-0452-2025
Class II · Moderate risk

BD ChloraPrep Clear

Lack of Assurance of Sterility: The affected product may exhibit an open seal on the packaging of the applicator.

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-31 D-0441-2025
Class II · Moderate risk

Celecoxib Capsules

Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules

Ongoing Particulate / foreign matter AvKARE NDC 50268-169-15 D-0460-2025
Class II · Moderate risk

Celecoxib Capsules

Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule

Ongoing Particulate / foreign matter Alembic Pharmaceuticals Limited NDC 62332-142-71 D-0459-2025

Recalls by year